ReciGen for treatment of Covid-19

Phase 3

Recruiting

• Conditions: Covid 19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20150914024017N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

patients who are diagnosed to have covid-19 based on Chest Ct Scan
patients being admitted to emergency room based on local guidelines
age 18 years or loder

Exclusion Criteria

pregnancy
breast feeding
do not consent to be in this study
allergies to interferon
not having a proper phone number for follow up calls

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospital stay. Timepoint: discharge date. Method of measurement: checklist.;Need for ICU admission. Timepoint: discharge date. Method of measurement: check list based on treating clinicians judgment.;Need for intubation. Timepoint: discharge date. Method of measurement: check list based on treating clinicians judgment.

Secondary Outcome Measures

Name	Time	Method
O2 saturation. Timepoint: daily. Method of measurement: pulse oxymeter.;Fever. Timepoint: daily. Method of measurement: thermometer.;Side effects. Timepoint: daily. Method of measurement: check list based on treating clinicians judgment.